Introduction
iCAN is a groundbreaking Finnish Research Flagship dedicated to solving the cancer challenge through cutting-edge discovery and innovation. The flagship is at the interface of precision cancer medicine and digital health, with the aim of advancing research and providing innovative solutions to tackle cancer.
iCAN News and Events
iCAN Science Seminar on The impact of Mobile DNA in cancer with Prof. Jose Tubio
Mobile DNA contributes to the genomic instability observed in various cancers. Around half of all cancers exhibit somatic integrations of…
Opening event of the Postdoc Program iCANPOD: Inspiring talks, research highlights, and networking
The new iCANPOD postdoctoral program in Precision Cancer Medicine at the University of Helsinki was officially launched with an opening event on 26.11.2025 in Biomedicum, Helsinki. ICANPOD offers career development and…
iCAN Science Seminar on The tumor microenvironment in classic Hodgkin lymphoma with Assoc. Prof. Arjan Diepstra
Warm welcome to the iCAN Science Seminar with Assoc. Prof. Arjan Diepstra (University Medical Center Groningen) on The tumor microenvironment…
iCAN in Numbers
iCAN Study Participants
Company collaborations
iCAN Publications
Invention
Disclosures
Patents
External Funding
